Iskra guidelines on sore throat: Diagnostic and therapeutic approach - Croatian national guidelines;Smjernice iskra za grlobolju: Dijagnostički I terapijski pristup - Hrvatske nacionalne smjernice

Lijecnicki Vjesnik

Volumn 131, Issue 7-8, 2009, Pages 181-191

  Andraševic, Arjana Tambić ^a   Baudoin, Tomislav ^b   Vukelić, Dalibor ^a   Matanović, Suzana Mimica ^b   Bejuk, Danijela ^c   Puževski, Diana ^d   Abram, Maja ^e   Tešović, Goran ^a   Grgurev, Zdravko ^d   Tomac, Gordana ^d   Pristaš, Irina ^a  

^a Croatia   (Croatia)

^b UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^c University Hospital Sveti Duh   (Croatia)

^d Specljalistička Pedijatrijska Ordinacija ^*

^e UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Administration and dosage; Complications; Diagnosis; Drug therapy; Isolation and purification; Microbiology; Penicillins; Pharyngitis; Streptococcal infections; Streptococcus pyogenes; Surgery; Therapeutic use; Tonsillectomy; Tonsillitis

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHARYNGITIS; PRACTICE GUIDELINE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TONSILLECTOMY; TONSILLITIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PHARYNGITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TONSILLECTOMY; TONSILLITIS;

EID: 70349322999     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Mandell GL. Bennet JE, Dolin R, ur. Mandell, Douglas, and Bennett's Principles & Practice of Infectious Diseases. New York: Elsevier/Churchill Livingstone; 2005.
2. Robertson KA. Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 2005;5:11.
3. Denny FW. Wannamaker LW, Brink WR, Rammelkamp CH, Custer EA. Prevention of rheumatic fever: treatment of the preceding streptococcic infection. JAMA 1950;143:151-3.
4. Carapetis JR., Rheumatic Heart Disease in Developing Countries. N Engl J Med 2007;357:439-41.
5. Brown A. McDonald MI, Calma T. Rheumatic fever and social justice. Med J Aust 2007;186:557-8.
6. Quinn RW., Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever. Rev Infect Dis 1989;11:928-53.
7. Kassem AS. Zaher SR. An international comparison of the prevalence of streptococcal infections and rheumatic fever in children. Pediatr Ann 1992;21:835, 839-42.
8. Stollerman GH., Current issues in the prevention of rheumatic fever. Minerva Med 2002;93:371-87.
9. st century? Indian Heart J 2001;53:25-34.
10. Cooper RJ. Hoffman JR, Bartlett JG I sur. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001;134:509-17.
11. Taylor JL. Home JGR. Antibiotics, sore throats and acute nephritis. J R Coll Gen Pract 1983;33:783-6.
12. Goslings WR. Valkenburg HA, Bots AW, Lorrier JC. Attack rates of streptococcalpharyngitis, rheumatic fever and glomerulonephritis in the general population. N Engl J Med 1963;268:687-94.
13. Siegel AC. Johnson EE, Stollerman GH. Controlled studies of streptococcalpharyngitis in a pediatric population. N Engl J Med 1961;265:559-66.
14. Brumfitt W. Slater JD. Treatment of acute sore throat with penicillin. A controlled trial in young soldiers. Lancet 1957;1:8-11.
15. Chamovitz R. Catanzaro FJ, Stetson CA, Rammelkamp CH. Prevention of rheumatic fever by treatment of previous streptococcal infections. N Engl J Med 1954;251:466-71.
16. Brink WR. Rammelkamp CH, Denny FW, Wannamaker LW. Effect of penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis. Am J Med 1951;10:300-8.
17. The Dutch College of General Practitioners (NHG). The Dutch College of General Practitioners (NHG) Practice Guideline Acute sore throat, 1999. Dostupno na: http://nhg.artsennet.nl/upload/104/guidelines2/E11.htm. Pristup dana: 23.03.2009.
18. Scottish Intercollegiate Guidelines Network (SIGN). Management of Sore Throat and Indications for Tonsillectomy. Edinburgh: SIGN Publication, Royal College of Physicians, Number 34, 1999. Dostupno na:
19. Finnish Medical Society Duodecim. Sore Throat and Tonsilitis. U: EBM Guidelines. Evidence-Based Medicine. Helsinki: Wiley Interscience, John Wiley & Sons; 2005.
20. Bisno L. Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Infectious Diseases Society of America. IDSA Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis. Clin Infect Dis 2002;35:113-25.
21. The AGREE Collaboration. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument, 2001. Dostupno na: http://www.agreecollaboration. org/. Pristup dana: 23.03.2009.
22. Tambić-AndraŠević A, Tambič T. Rezistencija bakterijskih izolata u 2007. godini. U: Tambić-AndraŠević A, Tambić T, ur. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2007. g. Zagreb: Akademija medicinskih znanosti Hrvatske; 2008.
23. US Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research (AHCPR). EPC Evidence Reports. Methodology. Dostupno na: http://www.ahcpr.gov/clinic/epcindex.htm#methodology. Pristup dana 23.03.2009.
24. Ebell MH. Smith MA, Barry HC, Ives K, Carey M. The rational clinical examination. Does this patient have strep throat? JAMA 2000;284:2912-8.
25. Hoogendoom D., Acute rheumatism and glomerulonephritis; current clinical incidence and mortality in The Netherlands. Ned Tijdschr Geneeskd 1989;133:2334-8.
26. Caplan C., Case against the use of throat culture in the management of streptococcal pharyngitis. J Fam Pract 1979;8:485-90.
27. Feery BJ. Forsell P, Gulasekharam M. Streptococcal sore throat in general practice - a controlled study. Med J Aust 1976;1:989-91.
28. Dingle JH. Badger G, Jordan WS Jr, ur. Illness in the home. Cleveland: Case Western Reserve University Press; 1964, str. 97-119.
29. Canterin AA. Donadon V, Cignacco GB i sur. Epidemiology of group A beta-hemolytic streptococcus in the school population of Pordenone Province. Arch Sci Med 1978;135:623-36.
30. Nawaz H. Smith DS, Mazhari R, Katz, DL. Concordance of clinical judgment in the diagnosis of streptococcal pharyngitis. Acad Emerg Med 2000;10:1104-9.
31. Gerber MA., Comparison of throat cultures and rapid strep tests for diagnosis of streptococcal pharyngitis. Pediatr Infect Dis J 1989;8:820-4.
32. McIsaac WJ. Kellner JD, Aufricht P, Vanjaka A, Low D. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 2004;291:1587-95.
33. Hall MC. Kieke B, Gonzales R, Belongia EA. Spectrum bias of a rapid antigen detecion test for group A beta-hemolytic streptococcal pharynitis in a pediatric population. Pediatrics 2004;114:182-6.
34. Gerber MA., Treatment failures and carriers: perception or problems? Pediatr Infect Dis J 1994;13:576-9.
35. Kaplan EL. Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981;98:326-35.
36. Del Mar. CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. The Cochrane Database Syst Rev 2006 Oct. 18;(4):CD000023.
37. Randolph MF. Gerber MA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr 1985;106:870-5.
38. Middleton DB. D'Amico F, Merenstein JH. Standardized symptomatic treatment versus penicillin as initial therapy for streptococcal pharyngitis. J Pediatr 1988;113:1089-94.
39. Dajani A. Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease on the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995;96:758-64.
40. Casey JR. Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 2004;113:866-82.
41. Cohen R., Defining optimum treatment regimen for azithromycin in acute tonsillopharyngitis. Ped Infect Dis J 2004;23(Suppl. 2):S129-134.
42. Zwart S. Sachs AP, Ruijs GJ, Gubbels JW, Hoes AW, de Melker RA. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults. Br Med J 2000;320:150-4.
43. Pichichero ME. Disney FA, Talpey WB i sur. Adverse and beneficial effects of immediate treatment of Group A beta-hemolytic streptococcal pharyngitis with penicillin. Pediatr Infect Dis J 1987;6:635-43.
44. Dagnelie CF. van der Graaf Y, de Melker RA. Do patients with sore throat benefit from penicillin? A randomized, double-blind placebocontrolled clinical trial with penicillin V in general practice. Br J Gen Pract 1996;46:589-93.
45. El-Daher NT, Hijazi SS, Rawashdeh NM, al-Khalil IA, Abu-Ektaish FM, Abdel-Latif DI. Immediate vs. delayed treatment of group A betahemolytic streptococcal pharyngitis with penicilllin V. Pediatr Infect Dis J 1991;10:126-30.
46. Krober MS. Bass JW, Michels GN. Streptococcal pharyngitis. Placebocontrolled double-blind evaluation of clinical response to penicillin therapy. JAMA 1985;253:1271-4.
47. Schwartz RH. Wientzen RL Jr, Pedreira F, Feroli EJ, Mella GW, Guandolo VL. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy. JAMA 1981;246:1790-5.
48. Bisno AL., Acute pharyngitis. N Engl J Med 2001;333:205-11.
49. Pickering L. Baker CJ, Overturf GD, Prober CG. Red Book, 2003 Report of the Committee on Infectious Diseases. Elk Grove Village: American Academy of Pediatrics; 2003.
50. Cohen R. Reinert P, de La Rocque F, Levy C, Boucherat M, Robert M. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2002;21:297-303.
51. Casey JR. Pichichero ME. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis. Clin Infect Dis 2005;40:1748-55.
52. Vrhovac B. ur. Farmakoterapijski priručnik. Zagreb: Medicinska naklada; 2007.
53. Pichichero ME. Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 1991;10:275-81.
54. Syrogiannopoulos GA. Bozdogan B, Grivea IN i sur. Hellenic Antibiotic-Resistant Respiratory Pathogens Study Group. Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2004;23:857-65.
55. Takker U. Dzyublyk O, Busman T, Notario G. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients. Curr Med Res Opin 2003;19:421-9.
56. Portier H. Filipecki J, Weber P, Goldfarb G, Lethuaire D, Chauvin JP. Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study. J Antimicrob Chemother 2002;49:337-44.
57. Pichichero ME. Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: A meta analysis. Otoryn Head Neck Sur 2007;136:340-7.
58. Pichichero ME. Casey JR. Bacterial eradication rates with shortened courses of 2nd-and 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Diagn Microbiol Infect Dis 2007;59:127-30.
59. Scholz H., Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. Results depending on the children's age. Chemotherapy 2004;50:51-4.
60. Casey JR. Pichichero ME. Metaanalysis of short course antibiotic treatment for group a streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2005;24:909-17.
61. Bisno AL., Diagnosis and management of group A streptococcal pharyngitis. A practice guideline. Clin Infect Dis 1997;25:574-83.
62. Casey JR. Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis 2004;38:1526-34.
63. Pichichero ME. Casey JR. Comparison of European and U. S. results for cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis. Eur J Clin Microbiol Infect Dis 2006;25:354-64.
64. Strömberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis 1988;20:37-46.
65. Gooch WM, McLinn SE, Aronovitz GH i sur. Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis. Antimicrob Agents Chemother 1993;37:159-63.
66. Pichichero ME. Casey JR, Mayes T i sur. Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies. Pediatr Infect Dis J 2000;19:917-23.
67. Gerber MA., Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 1999;104:911-7.
68. Mahakit P. Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group A beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Clin Ther 2006;28:99-109.
69. Orrling A, Stjernquist-Desatnik A, Schalén C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis 1994;26:535-41.
70. Morita JY. Kahn E, Thompson T i sur. Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 2000;19:41-6.
71. Paradise JL. Bluestone CD, Rogers KD, Taylor FH. Efficacy of adenoidectomy in recurrent otitis media. Historical overview and preliminary results from a randomized, controlled trial. Ann Otol Rhinol Laryngol Suppl 1980;89:319-21.
72. Mckee WJ., The part played by adenoidectomy in the combined operation of tonsillectomy with adenoidectomy. Second part of a controlled study in children. Br J Prev Soc Med 1963;17:133-40.
73. Mawson SR. Adlington P, Evans M. A controlled study evaluation of adeno-tonsillectomy in children. J Laryngol Otol 1967;81:777-90.
74. Roydhouse N., A controlled study of adenotonsillectomy. Arch Otolaryngol 1970;92:611-6.
75. Camilleri AE. MacKenzie K, Gatehouse S. The effect of recurrent tonsillitis and tonsiilectomy on growth in childhood. Clin Otolaryngol Allied Sci 1995;20:153-7.
76. Williams EF, Woo P, Miller R, Kellman RM. The effects of adenotonsillectomy on growth in young children. Otolaryngol Head Neck Surg 1991;104:509-16.
77. Wald ER. Dashefsky B, Feidt C, Chiponis D, Byers C. Acute rheumatic fever in western Pennsylvania and tristate area. Pediatrics 1987;80:371-4.
78. Veasy LG. Wiedemeier SE, Orsmond GS i sur. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987;316:421-7.
79. Howe RW. Millar MR, Coast J i sur. A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat. Br J Gen Pract 1997;47:280-4.
80. Dagnelie CF. van der Graaf Y, De Melker RA. Do patients with sore throat benefit from penicillin? A randomized, double-blind placebocontrolled clinical trial with penicillin V in general practice. Br J Gen Pract 1996;46:589-93.
81. Webb KH. Kurtz SR. Use of high-sensitivity rapid strep test without culture confirmation of negative results: 2 year's experience. J Fam Pract 2000;49:34-8.
82. Pichichero ME., Group A Beta-hemolytic Streptococcal Infections. Pediatr Rev 1998;19:291-302.
83. Talkington DF. Schwartz B, Black CM i sur. Association of Phenotypic and Genotypic Characteristics of Invasive Streptococcus pyogenes Isolates with Clinical Components of Streptococcal Toxic Shock Syndrome. Infect Immun 1993;61:3369-74.
84. Pontes T. Antunes H. Group A beta-hemolytic streptococcal toxic shock. Acta Med Port 2004;17:395-8.
85. Eriksson BK. Norgren M, McGregor K, Spratt BG, Normark BH. Group A Streptococcal Infections in Sweden: A Comparative Study of Invasive and Noninvasive Infections and Analysis of Dominant T28 emm28 Isolates. Clin Infect Dis 2003;37:1189-93.
86. Eriksson BK. Norgren M, McGregor K, Spratt BG, Normark BH. Opsonization of T1M1 Group A Streptococcus: Dynamics of Antibody Production and Strain Specificity. Clin Infect Dis 2001;32:24-30.
87. Darenberg J. Luca-Harari B, Jasir A i sur. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 2007;45:450-8.
88. Shulman ST. Gerber MA, Tanz RR, Markowitz M. Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J 1994;13:1-7.
89. Kaplan El., The Group A Streptococcal Upper Respiratory Tract Carrier State: An Enigma. J Pediatr 1980;97:337-45.
90. Gray GC. Struewing JP, Hyams KC, Escamilla J, Tupponce AK, Kaplan EL. Interpreting a Single Antistreptolysin O Test: A Comparison of the »Upper limit of Normal« and Likelihood Ratio Methods. J Clin Epidemiol 1993;10:1181-5.